(Q36379406)

13 August 2017

1 reference

title

Epileptogenesis and rational therapeutic strategies (English)

1 reference

13 August 2017

Stefan H

1

1 reference

13 August 2017

Lopes da Silva FH

2

1 reference

13 August 2017

Löscher W

3

1 reference

13 August 2017

Schmidt D

4

1 reference

13 August 2017

Perucca E

5

1 reference

13 August 2017

Brodie MJ

6

1 reference

13 August 2017

Boon PA

7

1 reference

13 August 2017

Theodore WH

8

1 reference

13 August 2017

Moshé SL

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Acta Neurologica Scandinavica

13 August 2017

published in

1 reference

13 August 2017

volume

113

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

139-155

1 reference

Prognostic factors in the surgical treatment of medically intractable epilepsy associated with mesial temporal sclerosis.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Cavernous haemangiomas, epilepsy and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Long-lasting increased excitability differs in dentate gyrus vs. CA1 in freely moving chronic epileptic rats after electrically induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

GAP-43 mRNA and protein expression in the hippocampal and parahippocampal region during the course of epileptogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Current status and future directions in the pharmacotherapy of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

First seizure in adults: to treat or not to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

What can we learn from clinical trials of anticonvulsant drugs in epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Therapeutic-class wars--drug promotion in a competitive marketplace

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Translating monotherapy trials into clinical practice: a look into the abyss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Marketed new antiepileptic drugs: are they better than old-generation agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Refractory epilepsy: a progressive, intractable but preventable condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

The mechanisms of action of commonly used antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

MDR1 gene expression in brain of patients with medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

The impact of efflux transporters in the brain on the development of drugs for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Increased Expression of GABAAReceptor β-Subunits in the Hippocampus of Patients with Temporal Lobe Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

A novel mechanism underlying drug resistance in chronic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Clinical aspects and biological bases of drug-resistant epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Epilepsy and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Glutamic acid decarboxylase autoantibodies and neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Blood gene expression profiling of neurologic diseases: a pilot microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

The clinical impact of new antiepileptic drugs after a decade of use in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Place of polytherapy in the early treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

The natural history of epilepsy: an epidemiological view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Seizure frequency and the health-related quality of life of adults with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Obtaining a driver's license and seizure relapse in patients with childhood-onset epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Risk of recurrent seizures after two unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Long-term prognosis of seizures with onset in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

The risk of seizure recurrence following a first unprovoked seizure: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Progressive neocortical damage in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Spatial stability over time of brain areas generating fast ripples in the epileptic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Susceptibility of immature and adult brains to seizure effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

Seizure-associated hippocampal volume loss: A longitudinal magnetic resonance study of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00561.X

10.1111/J.1600-0404.2005.00561.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference